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Membrane-associated guanylate kinases (MAGUKs)
are the major family of scaffolding proteins at the
postsynaptic density. The PSD-MAGUK subfamily,
which includes PSD-95, PSD-93, SAP97, and
SAP102, is well accepted to be primarily involved in
the synaptic anchoring of numerous proteins, includ-
ing N-methyl-D-aspartate receptors (NMDARs).
Notably, the synaptic targeting of NMDARs depends
on the binding of the PDZ ligand on the GluN2B
subunit to MAGUK PDZ domains, as disruption of
this interaction dramatically decreases NMDAR
surface and synaptic expression. We recently re-
ported a secondary interaction between SAP102
and GluN2B, in addition to the PDZ interaction.
Here, we identify two critical residues on GluN2B
responsible for the non-PDZ binding to SAP102.
Strikingly, either mutation of these critical residues
or knockdown of endogenous SAP102 can rescue
the defective surface expression and synaptic locali-
zation of PDZ binding-deficient GluN2B. These
data reveal an unexpected, nonscaffolding role for
SAP102 in the synaptic clearance ofGluN2B-contain-
ing NMDARs.INTRODUCTION
NMDARs are ionotropic glutamate receptors that play important
roles in excitatory neurotransmission, synaptic plasticity, and
neuronal development (Lau and Zukin, 2007). Precise regulation
of NMDAR trafficking and synaptic localization is essential for
these functions. NMDARs are localized at the postsynaptic
membrane, and are stabilized through interactions with
membrane-associated guanylate kinases (MAGUKs)(Wenthold
et al., 2003). PSD-93, PSD-95, SAP97, and SAP102 are collec-
tively known as PSD-MAGUKs and possess three PDZ domains,1120 Cell Reports 2, 1120–1128, November 29, 2012 ª2012 The Auta Src homology 3 (SH3) domain and an inactive guanylate kinase
(GK) domain (Elias and Nicoll, 2007). The PDZ domains bind to
the C termini of NMDARs, whereas the SH3 and GK domains
interact with cytoskeletal proteins and intracellular signaling
complexes. Although PSD-MAGUKs share a common modular
structure, each family member possesses a distinct N-terminal
domain. The N termini of PSD-95, PSD-93, and SAP97 contain
either a pair of palmitoylated cysteines that stabilize them at
synapses or an L27 domain capable of multimerization (Schlu¨ter
et al., 2006). The N terminus of SAP102, however, is not palmi-
toylated and does not have an L27 domain and thus has an
unknown function. Recently, we found that the N terminus
of SAP102 contains a GluN2B-specific NMDAR binding site
(Chen et al., 2011).
Functional NMDARs are heterotetramers assembled with two
GluN1 subunits and two GluN2 (GluN2A-GluN2D) and/or GluN3
(GluN3A- GluN3B) subunits. The GluN2 subunits have distinct
expression patterns with GluN2A and GluN2B being the major
GluN2 subunits in the forebrain. The GluN2 content of NMDARs
determines their channel properties, as well as their coupling
to distinct intracellular signaling cascades (Cull-Candy and Lesz-
kiewicz, 2004). During development, GluN2B is predominantly
expressed in immature neurons and the expression of GluN2A
gradually increases, leading to a synaptic switch from GluN2B-
to primarily GluN2A-containing NMDARs. In mature neurons,
GluN2A-containing NMDARs are primarily localized at synapses,
whereas GluN2B-containing receptors are still present at
synapses, but also enriched at extrasynaptic sites (Li et al.,
2002; Stocca and Vicini, 1998; Tovar and Westbrook, 1999). In
addition, GluN2B-containing NMDARs undergo more robust
endocytosis (Lavezzari et al., 2004; Roche et al., 2001) and
have higher surface mobility than GluN2A-containing receptors
(Groc et al., 2006). Biochemical studies have shown that GluN2A
preferentially binds to PSD-95 andGluN2Bpreferentially binds to
SAP102 (Sans et al., 2000; van Zundert et al., 2004; although, see
Al-Hallaq et al., 2007), and it has been proposed that PSD-95 and
SAP102 play a role in the subunit-specific regulation of receptor
trafficking and localization (van Zundert et al., 2004). Interest-
ingly, SAP102 is not palmitoylated and is highly mobile at the
postsynaptic density, similar to GluN2B (Zheng et al., 2010).hors
GluN2A and GluN2B share an identical PDZ ligand. However,
we have recently identified a secondary non-PDZ GluN2B
binding site in the N-terminal domain of SAP102, which might
allow for preferential binding of SAP102 and GluN2B (Chen
et al., 2011). In the present study, we investigated the role of
the PDZ-independent interaction of GluN2B with SAP102 in
NMDAR trafficking. We identify two amino acids within the
GluN2B C terminus (D1391; D1392) that are critical for binding
to the SAP102 N-terminal domain.
Mutating the PDZ ligand on GluN2B profoundly reduces
surface expression of NMDARs (Chung et al., 2004; Prybylowski
et al., 2005) and the activity-dependent phosphorylation of
GluN2B within the PDZ ligand by casein kinase 2 (CK2) drives
the removal of GluN2B from the synapse (Sanz-Clemente
et al., 2010). We now show that disruption of the secondary
SAP102 binding site on GluN2B unexpectedly and dramatically
rescues the surface and synaptic expression of PDZ binding-
deficient GluN2B. Furthermore, RNAi knockdown of SAP102
also rescued the surface and synaptic expression defect of the
GluN2B PDZ ligand mutant. Together, our findings reveal an
unexpected role for the PDZ-independent interaction between
SAP102 and GluN2B in mediating the synaptic clearance of
GluN2B-containing NMDARs.
RESULTS
To identify the PDZ-independent SAP102 binding site in GluN2B,
we analyzed a series of GluN2B truncations using a yeast two-
hybrid assay. We found a region of the GluN2B C terminus
(amino acids 1353–1441) that is required for the non-PDZ inter-
action (Figure 1A), but attempts to delineate this region further
were limited by self-activation of the yeast two-hybrid system.
We next generated GluN2A-GluN2B chimeras and found that
the GluN2A (1304–1400)-GluN2B (1422–1482) chimera (Fig-
ure 1A) interacted with the SAP102 N-terminal domain (Fig-
ure 1A), suggesting a short region in GluN2B (1422–1441) is crit-
ical for the interaction. Surprisingly, however, this region alone
did not interact with the N terminus of SAP102. We therefore
postulated that the adjacent region of GluN2B (1353–1400) is a
key molecular determinant for binding to the SAP102 N-terminal
domain, whereas 1422–1441 is simply permissive but cannot
interact independently. Consistently, we found that GluN2B
(1–1441) and GluN2B (1–1400), but not GluN2B (1–1353), coim-
munoprecipitated with SAP102 (Figures 1A and S1). Based on
the chimeras, we hypothesized that the critical residues in the
GluN2B (1353–1400) segment must be conserved between
GluN2A and GluN2B, but that these residues only interact with
the SAP102 N terminus when the GluN2B (1422–1441) region
is also present. To test this possibility, we made specific amino
acid substitutions within GluN2B (1353–1400), which are iden-
tical in the analogous region of GluN2A (1304–1400) (Figure 1B).
We first targeted several charged residues and found that the
GluN2B D1391K and D1392K mutations (Figure 1B), but not
D1378K (Figure S1), disrupted the PDZ-independent binding to
SAP102. Moreover, the GluN2B D1391K and D1392K (GluN2B
DD-KK) double mutant further reduced the interaction (Fig-
ure 1B). We also examined the PDZ-independent interaction
using a coimmunoprecipitation assay in HEK293 cells express-Cell Reing GluN1, GluN2B DD-KK or GluN2B DD-KK S1480E, and
SAP102. We found that GluN2B DD-KK S1480E showed
a 54% reduction in SAP102 binding compared with GluN2B
S1480E (Figure 1B), demonstrating that GluN2B D1391 and
D1392 are involved in the interaction of GluN2B with the
SAP102 N terminus.
Phosphorylation of Ser1480 within the GluN2B PDZ-binding
motif by CK2 disrupts the interaction of GluN2B with PSD-95
and SAP102 and decreases surface expression of GluN2B
(Chung et al., 2004). However, the role of the PDZ-independent
interaction of GluN2B with SAP102 in NMDAR trafficking is
not known. Therefore, we used the GluN2B DD-KK double
mutant to study whether the PDZ-independent interaction with
SAP102 regulates surface expression of GluN2B. We expressed
GFP-GluN2B WT or GFP-GluN2B DD-KK in hippocampal
neurons and visualized surface-expressed receptors with an
anti-GFP antibody. Surface expression of GFP-GluN2B DD-KK
was similar to that of GFP-GluN2B WT (Figure 2). We then in-
vestigated whether disruption of both the PDZ and PDZ-
independent interactions could affect NMDAR trafficking. To
this end, we mutated Ser1480 of GluN2B to glutamate to mimic
phosphorylation of Ser1480, which disrupts the PDZ binding of
GluN2B and examined the surface expression of GFP-GluN2B
S1480E and a combined GFP-GluN2B DD-KK S1480E mutant.
Consistent with previous reports (Chung et al., 2004), surface
expression of GFP-GluN2B S1480E was dramatically reduced
compared to WT (Figure 2). Strikingly, surface expression was
recovered with GFP-GluN2B DD-KK S1480E and was similar
to wild-type GluN2B (Figure 2), demonstrating that DD-KKmuta-
tions, which disrupt binding to the SAP102 N terminus, rescue
the surface expression defect of GFP-GluN2B S1480E.
Disruption of an endocytic motif (YEKL) near the C terminus of
GluN2B that binds to the clathrin adaptor protein complex AP-2
also restores the surface expression of GluN2B that lacks PDZ
binding (Prybylowski et al., 2005; Sanz-Clemente et al., 2010)
Thus, to determine if the surface expression rescue seen with
the GluN2B DD-KK S1480E mutant (Figure 2) is due to
decreased AP-2 binding, we used a yeast two-hybrid binding
assay to examine the interaction of GluN2B with m2, the medium
chain of AP-2 that binds to the GluN2B YEKL motif (Lavezzari
et al., 2003). However, the DD-KK mutations had no effect on
GluN2B binding to m2 (Figure S2), showing that the rescue of
the surface expression of GluN2B S1480E is not mediated by
the disruption of AP-2 binding.
To physiologically assess the effects of GluN2B mutations on
the synaptic localization of NMDARs, we developed a genetic
molecular replacement strategy in organotypic hippocampal
slice cultures prepared from mice with conditional knockout
alleles for both GluN2A and GluN2B (Grin2afl/flGrin2bfl/fl)
(Granger et al., 2011). We have previously shown that neonatal
injection of a Cre-expressing virus into the hippocampus of
Grin2afl/flGrin2bfl/fl mice completely eliminates synaptic NMDAR
responses in CA1 pyramidal neurons by postnatal day 14, sug-
gesting that GluN2A and GluN2B account for all synaptic
NMDARs in these cells (Gray et al., 2011). Here, hippocampal
slice cultures prepared from the Grin2afl/flGrin2bfl/fl mice were
biolistically transfected with Cre at DIV2-4, and paired whole-
cell recordings were obtained from a Cre-expressing and aports 2, 1120–1128, November 29, 2012 ª2012 The Authors 1121
Figure 1. Two Critical Residues in GluN2B Regulate the PDZ-Independent Interaction with SAP102
(A) (1) Schematics of PDZ-dependent and PDZ-independent interactions between GluN2B and SAP102. Various constructs are shown aligned under full-length
GluN2B. The interaction of GluN2B constructs with the N-terminal domain of SAP102 are shown, as measured by the yeast two-hybrid binding assay.
s.a. indicates there was self activation of the expression construct so the interaction assay could not be performed. (2) HEK293 cells were transfected with
GFP-GluN2B (1–1482), GFP-GluN2B (1–1441), GFP-GluN2B (1–1400) or GFP-GluN2B (1–1353), and SAP102. Receptors were immunoprecipitated from cell
lysates with anti-GluN2B antibodies or IgG antibodies as a negative control. Immunoprecipitates were resolved by SDS-PAGE and immunoblotted with anti-
SAP102 or anti-GluN2B antibodies. Input = 10%of total cell lysate. The data were quantified bymeasuring co-IP/input SAP102 band intensity ratios using ImageJ
software. Data represent means ± SEM (n = 3 independent experiments). See also Figure S1.
(B) An alignment of GluN2A (1334–1382) and GluN2B (1353–1400) are shown. GluN2B D1378, D1391, and D1392 are indicated with arrowheads. The N3 domain
of SAP102 (101–148) is the minimum region required for the non-PDZ interaction (Chen et al., 2011). (1) Yeast were cotransformed with LexA-GluN2B, LexA-
GluN2BD1391K, LexA-GluN2BD1392K, or LexA-GluN2BD1391KD1392K andGal4 vector or Gal4-SAP102-N3, and growth was evaluated on appropriate yeast
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neighboring control cell at DIV18-24 (Figure 3A). Simultaneous
paired dual-cell recordings allow for a rigorous, quantitative
study of the postsynaptic effects of the genetic manipulation
while controlling for presynaptic inputs. As shown in Figure 3B,
2 weeks of Cre expression reduced the NMDAR-mediated
excitatory postsynaptic current (EPSC) by approximately 90%
of control cell levels. Longer incubation prior to recording would
likely reduce the EPSC further, though slice health becomes
limiting. Importantly, the duration of NMDAR-EPSC decays (tW)
of the small remaining currents were not different from control
(Figure 3B), suggesting that this small population of NMDARs
is similar in composition to control cells. When Cre was co-
expressed with a wild-type GluN2B construct, there was nearly
complete recovery (90%) of the NMDAR-EPSC, with the ex-
pected lengthening of the decay kinetics from an introduced
population of purely GluN2B-containing NMDARs (Figures 3C
and 3D).
To examine the role of the PDZ-independent interaction of
GluN2B with SAP102 in the synaptic localization of NMDARs,
we coexpressed Cre with the GluN2B DD-KK mutant. Con-
sistent with the surface expression studies in dispersed
neuronal cultures, the DD-KK mutant had synaptic NMDAR
currents similar to wild-type, whereas GluN2B S1480E did not
increase synaptic current over Cre alone (Figures 3C and 3D),
suggesting a complete exclusion of GluN2B S1480E from
synapses. Remarkably, adding the DD-KK mutation to the
S1480E mutant completely rescued the synaptic localization of
NMDARs (Figures 3C and 3D). Taken together, these results
show that the secondary, PDZ-independent, SAP102 binding
site on GluN2B precisely regulates the synaptic localization of
NMDARs.
We next investigated if SAP102 knockdown can also rescue
the surface expression defect of GluN2B S1480E. We generated
a small hairpin RNA (shRNA) that efficiently reduced expression
of SAP102 in dissociated cortical neurons (Figure S3) and trans-
duced neurons with lentivirus expressing the SAP102 shRNA at
DIV5 and expressed FLAG-GluN2B (WT or S1480E) at DIV10.We
again observed reduced surface expression for the GluN2B
S1480E mutant (Figure 4A). Notably, however, surface expres-
sion of GluN2B S1480E was markedly increased upon SAP102
knockdown, whereas there was no significant change in GluN2B
WT surface expression (Figure 4A). Using an shRNA against
mouse SAP102 (Figure S3), we knocked down SAP102 in the
mouse hippocampal slice culture system. Coexpressing mouse
SAP102 shRNA with the GluN2B S1480E mutant rescued
approximately 50% of the synaptic NMDAR-EPSC (Figures 4B
and 4C). This rescue was completely reversed by coexpression
of an shRNA-proofed full-length SAP102, but not a SAP102
splice variant lacking the I1 cassette in the N-terminal domain
(Figures 4B and 4C) (Chen et al., 2011). Importantly, knockdown
of PSD-95 did not rescue the synaptic expression of GluN2B
S1480E (Figures 4B, 4C, and S3). Taken together, these results
convincingly demonstrate a critical role for the PDZ-independentselection medium. Results shown are 10-fold serial dilutions of yeast cells. (2) H
Receptors were immunoprecipitated from cell lysates with anti-GluN1 antibodie
blotted with anti-SAP102 or anti-GluN2B antibodies. Input = 5% of total cell lysa
ratios using ImageJ software. Data represent means ± SEM (n = 3 independent
Cell ReSAP102 binding site on GluN2B in the synaptic removal of PDZ
binding-deficient GluN2B.
DISCUSSION
In this study, we have revealed a mechanism for the subunit-
specific regulation of NMDARs. First, we identify two critical
residues in the C terminus of GluN2B (DD-KK mutation) respon-
sible for the GluN2B interaction with the SAP102 N terminus.
Second, we show that mutation of these two critical residues
rescues the surface expression defect of PDZ binding-deficient
GluN2B. Third, we find that knocking down SAP102 also rescues
the surface expression defect of PDZ binding-deficient GluN2B,
providing powerful evidence that the DD-KK mutation on the
GluN2B C termini regulates surface expression via specific
binding to SAP102. Thus, the PDZ-independent interaction
between GluN2B and SAP102 plays an important role in the
trafficking and synaptic localization of the GluN2B-containing
NMDARs. These findings support a model in which SAP102
acts as an adaptor to regulate the lateral movement of
GluN2B-containing NMDARs from the synaptic to extrasynaptic
membrane (Figure 4D).
During development, the subunit composition of synaptic
NMDARs changes from mainly GluN2B-containing receptors to
primarily GluN2A-containing receptors. This subunit switch is
activity-dependent and underlies changes in the functional
properties of NMDARs including acceleration of the kinetics of
NMDAR-mediated EPSCs and increases in the channel open
probabilities (Barria and Malinow, 2002; Bellone and Nicoll,
2007; Gray et al., 2011; Philpot et al., 2001; Sanz-Clemente
et al., 2010). In addition, NMDARs are rapidly exchanged
between synaptic and extrasynaptic sites through lateral diffu-
sion in immature neurons (Tovar andWestbrook, 2002). It is clear
that the subunit composition of synaptic NMDARs can undergo
rapid and bidirectional switching depending on the pattern of
NMDAR activation at neonatal synapses (Bellone and Nicoll,
2007; Matta et al., 2011). However, the molecular mechanisms
underlying the differential NMDAR trafficking during devel-
opment and synaptic plasticity are unclear. It is clear that both
phosphorylation, and protein-protein interactions regulate
subunit-specific NMDAR trafficking (Chen and Roche, 2007). In
this study, we have uncovered a specific mechanism, which
regulates the trafficking and synaptic targeting of GluN2B-
containing NMDARs.
PSD-MAGUKs act as scaffolding proteins at the postsynaptic
density and organize various signal transduction cascades. Each
family member has unique properties, but they can functionally
compensate for each other (Elias and Nicoll, 2007). The expres-
sion of PSD-MAGUKs is differentially regulated during develop-
ment. For example, SAP102 is expressed early and is dominant
for trafficking and anchoring NMDARs at immature synapses
(Sans et al., 2003; Washbourne et al., 2004), whereas PSD-95
is expressed later and is involved in maturation and stabilizationEK293 cells were transfected with GluN1, SAP102, and GluN2B constructs.
s or IgG antibodies as a negative control. Immunoprecipitates were immuno-
te. The data were quantified by measuring Co-IP/input SAP102 band intensity
experiments; *p < 0.01). See also Figure S1.
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Figure 2. DD-KK Mutations Rescue the Surface Expression of
GluN2B S1480E in Neurons
Hippocampal neurons were transfected with GluN2B constructs containing an
extracellular GFP tag. Surface staining was performed with anti-GFP and
Alexa 568-conjugated (red) anti-rabbit secondary antibodies, followed by
fixation and permeabilization, and the internal pool of receptors was labeled
with anti-GFP and Alexa 488-conjugated (green) anti-rabbit secondary anti-
bodies. Data represent means ± SEM (n = 27; *p < 0.01) (n = 3 independent
experiments). See also Figure S2.
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synaptic function of PSD-95 has been extensively studied, there
are relatively few studies on SAP102. Mutations in the human
gene encoding SAP102 have been reported to cause mental
retardation (Tarpey et al., 2004; Zanni et al., 2010), indicating
that SAP102 plays a crucial role in synaptic function. Indeed,
mice lacking SAP102 display specific impairments in synaptic
plasticity and show cognitive deficits (Cuthbert et al., 2007).
However, how SAP102 regulates synaptic function remains
elusive. Using fluorescence recovery after photobleaching
(FRAP), studies have shown that the majority of SAP102 is highly
mobile in dendritic spines and themobility is rapidly regulated by
synaptic activity (Zheng et al., 2010). In contrast, only about
a third of PSD-95 is mobile and the mobility is not affected by
synaptic activity. Interestingly, studies using single molecule/
particle approaches have provided evidence that surface
GluN2A-containing NMDARs are much less mobile compared
to surface GluN2B-containing receptors (Groc et al., 2006).
These results are consistent with earlier studies showing prefer-
ential binding between GluN2B and SAP102 (Sans et al., 2000).
We have shown that the SAP102N terminus contains anNMDAR
binding site specific for GluN2B (Chen et al., 2011). We now have
been able to disrupt this non-PDZ binding by mutating two
critical residues in the GluN2B C terminus (DD-KK), although it
remains unclear if these residues represent a direct binding
site or if the mutations result in disruptive conformational
changes. Furthermore, we demonstrate that the specific interac-
tion between GluN2B and SAP102 is important for trafficking of
GluN2B-containing NMDARs out of the synapse. Based on our
findings, it is likely that the high surface mobility of GluN2B is
due to the preferential binding to SAP102, which is extremely
mobile in spines.
Glutamate receptor trafficking plays a major role in con-
trolling the number and type of functional receptors during
synaptic plasticity. Although endocytosis and exocytosis play
a critical role in trafficking of glutamate receptors and synaptic
plasticity, lateral diffusion is also important (Cognet et al.,
2006; Kennedy and Ehlers, 2006). Endocytic proteins, such
as clathrin, AP-2 and dynamin, are localized lateral to the
PSD, forming ‘‘endocytic zones,’’ allowing efficient endocytosis
of receptors that diffuse away from synapses (Ra´cz et al.,
2004). Therefore, it has been suggested that removal of
synaptic receptors is a two-step process: uncoupling of recep-
tors from the PSD, followed by lateral movement to an endo-
cytic zone (Ra´cz et al., 2004). Our studies identify a function
of SAP102 in regulating internalization of GluN2B-containing
receptors. Our model is consistent with the two-step process
of internalization (Figure 4D). First, phosphorylation of GluN2B
on S1480 within the PDZ ligand by CK2 disrupts the interaction
between synaptic NMDARs and synaptic MAGUKs, such as
PSD-95. Second, GluN2B bound to SAP102 through the
non-PDZ binding is laterally diffused to the endocytic zone.
Extrasynaptic GluN2B is dephosphorylated on Y1472, associ-
ates with the AP-2-clathrin endocytic complex, and undergoes
endocytosis. Our findings on the subunit-specific interactions
between GluN2B and SAP102 provide insight into MAGUK-
specific roles in regulating synaptic NMDARs, which were
previously unappreciated.hors
Figure 3. Disruption of Non-PDZ SAP102 Binding Rescues the Synaptic Targeting of PDZ-Deficient GluN2B
(A) Organotypic hippocampal slice cultures were made from P7 Grin2afl/flGrin2bfl/fl mice, biolistically transfected at DIV2-4, and paired whole-cell recordings
were obtained from Cre-expressing and neighboring CA1 pyramidal neurons at DIV18-24.
(B and C) Scatter plots of peak amplitudes of NMDAR-EPSCs from single pairs (open circles) and mean ± SEM (filled circles) from transfected and control cells.
Dashed lines represent linear regression and 95% confidence interval. Sample traces are as follows: control cell, black; transfected cell, green; scale bars
represent 100 ms and 40 pA. NMDAR-EPSC decay times expressed in ms as a weighted tau (tw) from paired transfected and control cells. (B) Transfection with
Cre alone. (C) Cotransfection of Cre with wild-type GluN2B, GluN2B DD-KK, GluN2B S1480E, or the double GluN2Bmutant DD-KK S1480E. Decay kinetics were
analyzed by a paired Student’s t test, *p < 0.0001.
(D) Summary graph of data. Bars represent the mean ± SEM of the ratios of transfected to control cells from each pair, expressed as percentages.
Data were analyzed by the Mann-Whitney U test, *p < 0.0001 compared with GluN2B-S1480E. Actual values for all data can be found in Table S1.
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Figure 4. SAP102 Controls GluN2B Synaptic Expression
(A) SAP102 was knocked down in hippocampal cultures by the lentiviral induction of a specific shRNA at DIV5 and Flag-tagged GluN2B constructs (WT or
S1480E) were transfected at DIV10. Surface staining was performed with anti-Flag and Alexa 568 secondary antibodies (red) and, after permeabilization, the
intracellular pool was labeled with anti-Flag and Alexa 663 secondary antibodies (green). n for GluN2BWT (+/ shRNA) = 26, 26; n for S1480E (+/ shRNA) = 35,
32 (n = 4 independent experiments). Data represent means ± SEM. *p < 0.001. See also Figure S3.
(B) Cotransfection of Cre with GluN2B S1480E, shRNA against mouse SAP102, shRNA-proof SAP102 variants (SAP102*), or shRNA against mouse PSD-95 in
hippocampal slice cultures from P7Grin2afl/flGrin2bfl/fl mice. Top, scatter plot of peak amplitudes of NMDAR-EPSCs from single pairs (open circles) and mean ±
SEM (filled circles) from transfected and control cells. Dashed lines represent linear regression and 95%confidence interval. Sample traces are as follows: control
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EXPERIMENTAL PROCEDURES
The use and care of animals used in this study followed the guidelines of the
GHSU, UCSF, and NIH Animal Research Advisory Committees. Yeast two-
hybrid assays were performed using L40 yeast strain cotransformed with
pBHA and pGAD10 constructs. Immunoprecipitation (IP) was performed at
24 hr after transfection with indicated antibodies. Immunocytochemistry
assays were performed in 14 DIV dissociated hippocampal cultures 2 days
after transfection with GluN2B constructs. Hippocampi were dissected
from P7 Grin2afl/flGrin2bfl/fl mice and cotransfected after 2–4 days in culture
with pFUGW-Cre:mCherry and either pCAG-GFP or pCAG-GluN2B-IRES-
GFP or mutants. Slices were cultured for an additional 14–20 days and
dual whole-cell patch-clamp recordings were performed from neighboring
CA1 pyramidal cells. NMDAR-EPSCs were recorded at +40 mV in the pres-
ence of 10 mM NBQX. Further details available in the Extended Experimental
Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, three
figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2012.09.024.LICENSING INFORMATION
This is an open-access article distributed under the terms of the Creative
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